Drawing for ELITEHEALTH.MD

USPTO serial 77474072

ELITEHEALTH.MD

Reviewed by CopyMark Law Group

Reg. 3664693Status 711
Filing date
Status date
Registration date
Aug 4, 2009
Examiner
HETZEL, DANNEAN
Law office
TMEG LAW OFFICE 106

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ELITEHEALTH.MD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Smiley

Scott D. Smiley The Concept Law Group, P.A.200 South Andrews Avenue, Suite 100Fort Lauderdale, FL 33301UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Medical services, namely, providing concierge medical servicesSECTION 7(e) - CANCELLEDMay 2, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2015C7..CANCELLED SECTION 7-TOTAL—
Sep 3, 2015C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED—
Sep 3, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 3, 2015ES7STEAS SECTION 7 SURRENDER RECEIVED—
Sep 2, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 4, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2009REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jul 1, 2009CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 1, 2009SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 1, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 7, 2009IUAFUSE AMENDMENT FILED—
Jun 7, 2009EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 17, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 23, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2008NPUBNOTICE OF PUBLICATION—
Nov 18, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 18, 2008ALIEASSIGNED TO LIE—
Nov 13, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2008ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 29, 2008GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 29, 2008GNSLLETTER OF SUSPENSION E-MAILED—
Aug 29, 2008CNSLSUSPENSION LETTER WRITTEN—
Aug 29, 2008DOCKASSIGNED TO EXAMINER—
May 20, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
May 19, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance